Ho, C. S., Feng, P.-J., Narita, M., Stout, J. E., Chen, M., Pascopella, L., … Tuberculosis Epidemiologic Studies Consortium. (2022). Discordant results of tests for tuberculosis reconsidered - Authors' reply. Lancet Infect Dis, 22(2), 164–165. https://doi.org/10.1016/S1473-3099(21)00805-7

Ho, Christine S., Pei-Jean Feng, Masahiro Narita, Jason E. Stout, Michael Chen, Lisa Pascopella, Richard Garfein, Randall Reves, Dolly J. Katz, and Tuberculosis Epidemiologic Studies Consortium. “Discordant results of tests for tuberculosis reconsidered - Authors' reply.” Lancet Infect Dis 22, no. 2 (February 2022): 164–65. https://doi.org/10.1016/S1473-3099(21)00805-7.

Ho CS, Feng P-J, Narita M, Stout JE, Chen M, Pascopella L, et al. Discordant results of tests for tuberculosis reconsidered - Authors' reply. Lancet Infect Dis. 2022 Feb;22(2):164–5.

Ho, Christine S., et al. “Discordant results of tests for tuberculosis reconsidered - Authors' reply.” Lancet Infect Dis, vol. 22, no. 2, Feb. 2022, pp. 164–65. Pubmed, doi:10.1016/S1473-3099(21)00805-7.

Ho CS, Feng P-J, Narita M, Stout JE, Chen M, Pascopella L, Garfein R, Reves R, Katz DJ, Tuberculosis Epidemiologic Studies Consortium. Discordant results of tests for tuberculosis reconsidered - Authors' reply. Lancet Infect Dis. 2022 Feb;22(2):164–165.